Objective Guidelines recommend initiating anticoagulation within 4 to 14 days after
cardioembolic stroke. Data supporting this did not account for key factors potentially affecting …

Background and purpose A subset of ischaemic stroke patients with atrial fibrillation (AF)
have ischaemic stroke despite anticoagulation. We sought to determine the association …

Background Most patients with cardioembolic stroke require long-term anticoagulation. Still,
uncertainty exists regarding the best mode of starting long-term anticoagulation. Design …

Rationale Atrial fibrillation causes one-fifth of ischemic strokes, with a high risk of early
recurrence. Although long-term anticoagulation is highly effective for stroke prevention in …

Background and Purpose—The role of anticoagulant treatment for acute cardioembolic
stroke is uncertain. We performed an updated meta-analysis of all randomized trials to …

Background and Purpose—The best time for administering anticoagulation therapy in acute
cardioembolic stroke remains unclear. This prospective cohort study of patients with acute …

Background and Purpose Oral anticoagulants (OACs) prevent stroke recurrence and
vascular embolism in patients with acute ischemic stroke (AIS) and atrial fibrillation (AF) …

Background Cardioembolic stroke (CES) due to atrial fibrillation (AF) is associated with high
stroke mortality. Oral anticoagulation (OAC) reduces stroke mortality, however, the impact of …

Background The optimal time to commence anticoagulation in patients with atrial fibrillation
(AF) after ischaemic stroke or transient ischaemic attack (TIA) is unclear, with guidelines …

Background and purpose The optimal time to start oral anticoagulant (OAC) in patients with
ischaemic stroke due to non-valvular atrial fibrillation (AF) is unknown. We reviewed OAC …